Surviving cancer without the side-effects

Wouldn’t it be wonderful if women diagnosed with breast cancer could be treated without chemotherapy and its side-effects? According to a ground-breaking new clinical trial, funded in part by donors like you, safely skipping chemotherapy could be possible for some women.

The study followed over 10,000 women with early-stage breast cancer and used genetic tests to indicate the risk level for cancer relapse in each individual. Those deemed to be at medium risk were divided into two groups. One group received a combination of chemotherapy and hormone therapy, while the other group received only hormone therapy – without any chemo.

After nine years, women in both groups shared similar survival rates. These results indicate that genetic testing can accurately determine who requires chemotherapy and who does not.

This exciting discovery could reshape the course of breast cancer treatments in the future. Many women with breast cancer could enjoy improved quality of life by skipping chemotherapy without hurting their chances of survival.

With your support, last year we invested $16.4 million in cutting-edge breast cancer research like this study. Thank you for helping to make a difference in the lives of women with breast cancer.